FDA Roundup: October 21, 2022
FDA Roundup: October 21, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-21-2022
FDA Roundup: October 18, 2022
FDA Roundup: October 18, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-18-2022
FDA, DOJ Seek Permanent Injunctions Against Six E-cigarette Manufacturers
FDA, DOJ Seek Permanent Injunctions Against Six E-cigarette Manufacturers
http://www.fda.gov/news-events/press-announcements/fda-doj-seek-permanent-injunctions-against-six-e-cigarette-manufacturers
FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS
FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS
http://www.fda.gov/news-events/press-announcements/fda-awards-19-grants-and-two-contracts-related-rare-diseases-including-als
FDA Roundup: October 14, 2022
FDA Roundup: October 14, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-14-2022
Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL Vial, 20-Count Carton Due to Vial Breakage
Vosoritide para acondroplasia con epífisis abierta
Vosoritide para acondroplasia con epífisis abierta
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1397008
Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups
Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-bivalent-covid-19-vaccines